Logo image of CFX.DE

CAPITAL ONE FINANCIAL CORP (CFX.DE) Stock Fundamental Analysis

Europe - FRA:CFX - US14040H1059 - Common Stock

189 EUR
-3 (-1.56%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, CFX scores 4 out of 10 in our fundamental rating. CFX was compared to 8 industry peers in the Consumer Finance industry. The financial health of CFX is average, but there are quite some concerns on its profitability. CFX has a correct valuation and a medium growth rate. Finally CFX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CFX was profitable.
In the past year CFX had a positive cash flow from operations.
CFX had positive earnings in each of the past 5 years.
Each year in the past 5 years CFX had a positive operating cash flow.
CFX.DE Yearly Net Income VS EBIT VS OCF VS FCFCFX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

CFX has a Return On Assets of -0.05%. This is in the lower half of the industry: CFX underperforms 75.00% of its industry peers.
CFX has a Return On Equity of -0.27%. This is in the lower half of the industry: CFX underperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA -0.05%
ROE -0.27%
ROIC N/A
ROA(3y)1.14%
ROA(5y)1.35%
ROE(3y)9.53%
ROE(5y)10.43%
ROIC(3y)N/A
ROIC(5y)N/A
CFX.DE Yearly ROA, ROE, ROICCFX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

In the last couple of years the Profit Margin of CFX has declined.
CFX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-33.88%
PM growth 5Y-8.95%
GM growth 3YN/A
GM growth 5YN/A
CFX.DE Yearly Profit, Operating, Gross MarginsCFX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

CFX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CFX has more shares outstanding than it did 1 year ago.
CFX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CFX has been reduced compared to a year ago.
CFX.DE Yearly Shares OutstandingCFX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CFX.DE Yearly Total Debt VS Total AssetsCFX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

CFX has a debt to FCF ratio of 2.86. This is a good value and a sign of high solvency as CFX would need 2.86 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.86, CFX belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
A Debt/Equity ratio of 0.47 indicates that CFX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.47, CFX belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.86
Altman-Z N/A
ROIC/WACCN/A
WACC15.71%
CFX.DE Yearly LT Debt VS Equity VS FCFCFX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CFX.DE Yearly Current Assets VS Current LiabilitesCFX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

6

3. Growth

3.1 Past

CFX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.44%, which is quite impressive.
The Earnings Per Share has been growing slightly by 4.14% on average over the past years.
CFX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.01%.
The Revenue has been growing slightly by 6.47% on average over the past years.
EPS 1Y (TTM)31.44%
EPS 3Y-19.6%
EPS 5Y4.14%
EPS Q2Q%74.52%
Revenue 1Y (TTM)13.01%
Revenue growth 3Y8.72%
Revenue growth 5Y6.47%
Sales Q2Q%31.41%

3.2 Future

Based on estimates for the next years, CFX will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.88% on average per year.
The Revenue is expected to grow by 11.90% on average over the next years. This is quite good.
EPS Next Y26.15%
EPS Next 2Y19.1%
EPS Next 3Y21.11%
EPS Next 5Y10.88%
Revenue Next Year34.87%
Revenue Next 2Y26.33%
Revenue Next 3Y18.98%
Revenue Next 5Y11.9%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CFX.DE Yearly Revenue VS EstimatesCFX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B
CFX.DE Yearly EPS VS EstimatesCFX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20 25

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.03 indicates a correct valuation of CFX.
Based on the Price/Earnings ratio, CFX is valued cheaper than 87.50% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.38. CFX is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 11.29 indicates a reasonable valuation of CFX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CFX indicates a somewhat cheap valuation: CFX is cheaper than 62.50% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.86. CFX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.03
Fwd PE 11.29
CFX.DE Price Earnings VS Forward Price EarningsCFX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CFX is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.84
EV/EBITDA N/A
CFX.DE Per share dataCFX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

CFX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CFX's earnings are expected to grow with 21.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)3.15
EPS Next 2Y19.1%
EPS Next 3Y21.11%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.96%, CFX is a good candidate for dividend investing.
CFX's Dividend Yield is rather good when compared to the industry average which is at 4.00. CFX pays more dividend than 87.50% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, CFX pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.96%

5.2 History

The dividend of CFX is nicely growing with an annual growth rate of 6.34%!
Dividend Growth(5Y)6.34%
Div Incr Years0
Div Non Decr Years3
CFX.DE Yearly Dividends per shareCFX.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

The earnings of CFX are negative and hence is the payout ratio. CFX will probably not be able to sustain this dividend level.
The dividend of CFX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-439.53%
EPS Next 2Y19.1%
EPS Next 3Y21.11%
CFX.DE Yearly Income VS Free CF VS DividendCFX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

CAPITAL ONE FINANCIAL CORP

FRA:CFX (9/16/2025, 7:00:00 PM)

189

-3 (-1.56%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)07-22 2025-07-22/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners58.84%
Inst Owner ChangeN/A
Ins Owners0.76%
Ins Owner ChangeN/A
Market Cap120.87B
Analysts81.43
Price Target220.37 (16.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.96%
Yearly Dividend2.6
Dividend Growth(5Y)6.34%
DP-439.53%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.41%
Min EPS beat(2)8.83%
Max EPS beat(2)45.98%
EPS beat(4)4
Avg EPS beat(4)20.53%
Min EPS beat(4)8.56%
Max EPS beat(4)45.98%
EPS beat(8)5
Avg EPS beat(8)11.53%
EPS beat(12)6
Avg EPS beat(12)1.16%
EPS beat(16)9
Avg EPS beat(16)2.41%
Revenue beat(2)0
Avg Revenue beat(2)-2.04%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-1.47%
Revenue beat(4)1
Avg Revenue beat(4)-1.18%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)0.54%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)3
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)-0.38%
PT rev (1m)-0.78%
PT rev (3m)12.99%
EPS NQ rev (1m)0.69%
EPS NQ rev (3m)4.57%
EPS NY rev (1m)10.69%
EPS NY rev (3m)10.78%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)-0.54%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.62%
Valuation
Industry RankSector Rank
PE 13.03
Fwd PE 11.29
P/S 3.35
P/FCF 7.84
P/OCF 7.27
P/B 1.29
P/tB 2.22
EV/EBITDA N/A
EPS(TTM)14.5
EY7.67%
EPS(NY)16.74
Fwd EY8.86%
FCF(TTM)24.11
FCFY12.76%
OCF(TTM)25.99
OCFY13.75%
SpS56.49
BVpS146.81
TBVpS85.3
PEG (NY)0.5
PEG (5Y)3.15
Profitability
Industry RankSector Rank
ROA -0.05%
ROE -0.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 42.68%
ROA(3y)1.14%
ROA(5y)1.35%
ROE(3y)9.53%
ROE(5y)10.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-33.88%
PM growth 5Y-8.95%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.86
Debt/EBITDA N/A
Cap/Depr 41.1%
Cap/Sales 3.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC15.71%
ROIC/WACCN/A
Cap/Depr(3y)32.03%
Cap/Depr(5y)27.28%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.64%
Profit Quality(3y)330.76%
Profit Quality(5y)352.51%
High Growth Momentum
Growth
EPS 1Y (TTM)31.44%
EPS 3Y-19.6%
EPS 5Y4.14%
EPS Q2Q%74.52%
EPS Next Y26.15%
EPS Next 2Y19.1%
EPS Next 3Y21.11%
EPS Next 5Y10.88%
Revenue 1Y (TTM)13.01%
Revenue growth 3Y8.72%
Revenue growth 5Y6.47%
Sales Q2Q%31.41%
Revenue Next Year34.87%
Revenue Next 2Y26.33%
Revenue Next 3Y18.98%
Revenue Next 5Y11.9%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11.61%
FCF growth 3Y13.45%
FCF growth 5Y1.48%
OCF growth 1Y13.65%
OCF growth 3Y13.84%
OCF growth 5Y1.76%